Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer

scientific article published on October 2005

Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/0008-5472.CAN-05-0961
P698PubMed publication ID16204068

P50authorUltan McDermottQ39992201
Wendy L AllenQ56056799
P2093author name stringPatrick G Johnston
Daniel B Longley
Leeona Galligan
Timothy Wilson
P433issue19
P407language of work or nameEnglishQ1860
P921main subjectcolorectal cancerQ188874
P304page(s)8951-8960
P577publication date2005-10-01
P1433published inCancer ResearchQ326097
P1476titleEffect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer
P478volume65

Reverse relations

cites work (P2860)
Q39530180Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3.
Q46634635Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model
Q89003018C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer
Q39803115Camptothecin induces apoptosis of human retinoblastoma cells via activation of FOXO1.
Q39407582Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer
Q34547088Crude extract of Rheum palmatum L induced cell death in LS1034 human colon cancer cells acts through the caspase-dependent and -independent pathways
Q36588920Delivery of intracellular-acting biologics in pro-apoptotic therapies
Q37666015Emerging roles of p53 and other tumour-suppressor genes in immune regulation
Q39903499Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells
Q40054238Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents
Q36084498Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis
Q43950442Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer
Q39937932In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Q37571729Irinotecan therapy and molecular targets in colorectal cancer: a systemic review
Q93023701Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer
Q35955331Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.
Q36193189Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells.
Q64884447Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells.
Q80455307STAT1 activation in squamous cell cancer of the oral cavity: a potential predictive marker of response to adjuvant chemotherapy
Q37177918TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
Q38846369Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis

Search more.